Frontotemporal dementia: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Source

• A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary Tauopathies

  NCT07868328· Novartis Pharmaceuticals· Source

• ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

  NCT04363684· Mayo Clinic· Source

• Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

  NCT05326750· Kuopio University Hospital· Source

• Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· University of Southern California· Source

• A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.

  NCT06823752· Woolcock Institute of Medical Research· Source

• Remotely-supervised Neuromodulation in PPA

  NCT07260253· Maya Henry· Source

• Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

  NCT06856850· Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta· Source

• Longitudinal Early-onset Alzheimer's Disease Study Protocol

  NCT03507257· Indiana University· Source

• Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

  NCT05331144· Rong Zhang· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 1
• Organoids 4
• Mendelian Randomization Analysis 10
• CRISPR-Cas Systems 1
• Gene Expression Profiling 4
• Whole Genome Sequencing 3
• Exome Sequencing 1
• Proteomics 16
• Metabolomics 1
• Mass Spectrometry 1
• Flow Cytometry 2
• Immunohistochemistry 1
• Positron-Emission Tomography 28
• Magnetic Resonance Imaging 72
• Machine Learning 18
• Deep Learning 9
• Cohort Studies 34
• Genome-Wide Association Study 13

• Multidomain Electroencephalography Biomarker Fusion for Machine Learning-Based Dementia Classification.

  J Vis Exp, Sept 2026

• Machine learning for predicting full-count FDG PET brain images from low-count acquisitions in suspected dementia: a clinical and quantitative evaluation.

  Phys Med Biol, Aug 2026

• Comparative Screening of Alzheimer's Disease, Lewy Body Dementia, and Frontotemporal Dementia Using miRNA and Machine Learning.

  Int J Neural Syst, Jul 2026

• Explainable EEG-based machine learning for early diagnosis of Alzheimer's disease and frontotemporal dementia.

  Sci Rep, Jun 2026

• Dementia etiology classification using NULISA plasma biomarkers and machine learning.

  Alzheimers Dement, Jun 2026

• Speech-based digital biomarkers for early etiological stratification of Alzheimer's disease and frontotemporal degeneration: a biomarker-confirmed prospective study.

  J Prev Alzheimers Dis, Apr 2026

• Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism.

  Ann Neurol, Mar 2026

• Identifying neuropathologic disease in primary progressive aphasia using narrative speech.

  Alzheimers Dement, Mar 2026

• Graph empirical mode decomposition and multiscale feature extraction for EEG-based classification of Alzheimer's disease and frontotemporal dementia.

  Comput Methods Programs Biomed, Feb 2026

• A Unique EEG-Hyfusion Fully Automated Stacked Model for Classification of Alzheimer's Disease and Fronto-Temporal Dementia.

  J Vis Exp, Feb 2026

See which targets of this disease your abstract mentions, and go to the people working on them.